Cargando…

Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer

SIMPLE SUMMARY: Radiation is the standard of care for prostate cancer, but almost half the patients develop resistant disease. It is imperative to understand the reasons behind disease progression to develop more effective strategies of treatment. We determined that glutamine is a crucial nutrient i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiruvalluvan, Manish, Billet, Sandrine, Bhowmick, Neil A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139225/ https://www.ncbi.nlm.nih.gov/pubmed/35626095 http://dx.doi.org/10.3390/cancers14102491

Ejemplares similares

Antagonizing CD105 enhances radiation sensitivity in prostate cancer
por: Madhav, Anisha, et al.
Publicado: (2018)

Stromal–Epithelial Interactions in Cancer Progression and Therapy Response
por: Thiruvalluvan, Manish, et al.
Publicado: (2023)

Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance
por: Haldar, Subhash, et al.
Publicado: (2020)

Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol
por: Gong, Jun, et al.
Publicado: (2023)

Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
por: Salem, Ahmed F., et al.
Publicado: (2020)

Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism
por: Olsen, Rachelle R., et al.
Publicado: (2015)

Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017)

Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner
por: Zhang, Le, et al.
Publicado: (2022)

Glutamine antagonism attenuates physical and cognitive deficits in a model of MS
por: Hollinger, Kristen R., et al.
Publicado: (2019)

Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance
por: Liu, Chuanxia, et al.
Publicado: (2020)

The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
por: Shin, Chun-Shik, et al.
Publicado: (2017)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Inhibition of glutamine uptake regulates mTORC1, glutamine metabolism and cell growth in prostate cancer
por: Wang, Qian, et al.
Publicado: (2014)

A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
por: Wang, Hai, et al.
Publicado: (2023)

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer
por: Costea, Teodora, et al.
Publicado: (2019)

ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma
por: Zhang, Le, et al.
Publicado: (2023)

Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
por: Mukha, Anna, et al.
Publicado: (2021)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Chen, Ru, et al.
Publicado: (2017)

Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
por: Zacharias, Niki Marie, et al.
Publicado: (2017)

Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells
por: Cheng, Ran, et al.
Publicado: (2019)

Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy
por: Anderson, Peter M., et al.
Publicado: (2020)

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
por: Prensner, John R., et al.
Publicado: (2013)

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019)

EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism
por: Modernelli, Alice, et al.
Publicado: (2015)

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate
por: Salem, Ahmed F., et al.
Publicado: (2018)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
por: Aksoy, Osman, et al.
Publicado: (2020)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer
por: Meyer, Kevin A., et al.
Publicado: (2016)

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
por: Kroon, Jan, et al.
Publicado: (2016)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
por: Muir, Alexander, et al.
Publicado: (2017)

Effects of L-Glutamine oral supplementation on prostate of irradiated rats
por: Pinto, Flavia C. M., et al.
Publicado: (2016)

PKM2 promotes reductive glutamine metabolism
por: Liu, Miao, et al.
Publicado: (2018)

Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism
por: Zhou, Wen-Jie, et al.
Publicado: (2019)

B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
por: Zhou, Yunfen, et al.
Publicado: (2020)

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
por: Quek, Lake-Ee, et al.
Publicado: (2022)

Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
por: Medhora, Meetha, et al.
Publicado: (2021)

Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
por: Recouvreux, Maria Victoria, et al.
Publicado: (2020)

Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism
por: Shah, Supriya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qotibcef1kf9arn8od3j7t97vq